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Abstract
Background: Breathing and swallowing are physiologically linked to ensure effortless gas exchange during
oronasal breathing and to prevent aspiration during swallowing. Studies have indicated consistent aspiration in
chronic obstructive pulmonary disease, mainly related to delayed swallowing reflex and problems with lingual
propulsion and pharyngeal peristalsis as a result of bilateral weakness and incoordination of the related muscles.
The purpose of the present study was to evaluate swallowing transit times and valleculae residue characteristics of
stable COPD patients who have no swallowing complaints.
Methods: Our study population included 20 stable patients with COPD and no swallowing complaints and 20
healthy controls. Swallowing was assessed through videofluoroscopic examination and involved the analysis of the
following parameters: (1) pharyngeal stages of deglutition; (2) the duration of bolus movement through the oral
cavity and pharynx (i.e. transit times); (3) valleculae residue ratio; (4) penetration/aspiration.
Results: Participants of the study did not present any signs of penetration-aspiration for any of the tested
consistencies. Patients with COPD presented longer pharyngeal transit times during the ingestion of the liquid
consistency and during the ingestion of the paste consistency. Regarding the duration of tongue base contact with
the posterior pharyngeal wall, COPD patients also presented longer durations for the liquid and paste consistencies.
No significant difference was observed for the distribution of individuals among the different valleculae residue
severity levels.
Conclusions: Our study suggests that stable COPD patients may present physiological adaptations as a protective
swallowing maneuver to avoid aspiration/penetration of pharyngeal contents. Moreover, valleculae residue cannot
be seen as an isolated factor when trying to explain swallowing alterations in this population.
Keywords: COPD, Videofluoroscopy, Swallowing, Swallowing disorders
Background
Chronic obstructive pulmonary disease (COPD) is a major
cause of chronic morbidity and mortality and represents a
substantial economic and social burden throughout the
world [1]. It is the fourth-leading cause of death in the
United States and Europe and the burden of COPD is
likely to worsen as the population continues to age [2]. In
Brazil, COPD is the third-leading cause of death, having
presented a 12% increase between 2005 and 2010 [3]. This
means that nearly 40,000 deaths/year are caused by
COPD. It is estimated that 5 to 6 million Brazilians have
COPD, and patients tend to be mostly concentrated in the
age groups above 50 years [4].
Poor nutritional status of COPD patients has been re-
lated to adverse effects that may contribute to complica-
tions and increased mortality [5]. Malnutrition is due to
decreased food intake, but mostly to a higher resting
metabolic rate [6]. Dysphagia is usually a precipitating
factor for malnutrition [7-10]. To date, little attention
has been given to the investigation of swallowing disor-
ders in patients with COPD. Prevalence of dysphagia in
COPD varies considerably across studies [11,12] and the
basis for dysphagia is still uncertain.
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One of the reasons for patients with COPD to be con-
sidered at risk for dysphagia, or at least for presenting
some swallowing impairment is the fact that swallowing
and respiration are coordinated functions, i.e. respiration
halts when the swallowing reflex is triggered [13]. Breath-
ing and swallowing are physiologically linked to ensure ef-
fortless gas exchange during oronasal breathing and to
prevent aspiration during swallowing [14]. The literature
suggests that the respiratory system may have a regulatory
function related to swallowing and that subglottic air
pressure may be important for swallowing integrity [15].
According to Gross et al. [15], feedback mechanisms that
use afferent information from the subglottis may be more
readily accessed at higher lung volumes or during exhal-
ation when it is easiest to produce positive air pressure.
Coelho [16] suggested that COPD may weaken the
strength to swallow. Muscle structure and function are fre-
quently abnormal in patients COPD [17,18]. Muscle dys-
function is defined as the loss of at least one of the two
main muscle properties: strength and endurance [19].
Studies have indicated consistent aspiration in COPD pa-
tients, mainly related to delayed swallowing reflex [16,20]
and problems with lingual and pharyngeal peristalsis as a
result of bilateral weakness and incoordination of the re-
lated muscles [16]. When combined with an impaired
ability to use expired air to clear the larynx and protect the
airway, a weak swallow may contribute to an increased risk
for aspiration of pharyngeal contents, and may conse-
quently lead to aspiration pneumonia [21]. More recently,
Cvejic et al. [22] provided important evidence of aspiration
during swallowing in patients with stable moderate COPD
assessed by videofluoroscopy while respiration was moni-
tored. They found that patients with COPD were more
likely to have either penetration of pharyngeal contents
into the larynx or actual aspiration when swallowing large
volumes of liquid consistency (i.e. 100 ml).
Moreover, impaired laryngopharyngeal sensitivity may
be clinically important in COPD patients, especially for
those who have high rates of hospitalization related to
lower respiratory tract infection [21]. Although the cause
of impaired laryngopharyngeal sensitivity remains unclear,
a few hypothesis have been risen: the use of inhaled coriti-
costeroids and anticholinergics may have an effect on the
sensory mucosa of the laryngopharynx; laryngeal edema
caused by smoking and presence of chronic cough, com-
monly reported in COPD patients, may contribute to re-
duced sensation [21].
The purpose of the present study was to evaluate swal-
lowing transit times and valleculae residue characteris-
tics of stable COPD patients who have no swallowing
complaints. Considering the alterations described above,
our hypothesis was that although stable and not present-
ing swallowing complaints, patients with COPD should
present signs of altered swallowing (i.e. larger amounts
of valleculae residue and alterations in swallowing transit
times) when compared to their healthy pairs.
Methods
Study participants
An observational, descriptive, cross-sectional study was
conducted with COPD patients who were seen at the
COPD Ambulatory of a large Brazilian School Hospital
(Hospital das Clínicas), and healthy volunteers. The study
design was approved by the Ethics Committee for the
Analysis of Research Projects (CAPPesq HCFMUSP no.
0074/08). Prior to their enrollment, all participants were
informed of the purpose and procedures, after which all
gave written informed consent.
The assessment of swallowing was only performed in
the subjects with COPD after verifying if they were in a
stable condition, i.e. no exacerbation of symptoms for at
least the past 30 days, as confirmed by the medical team
[23,24]. The inclusion criteria for patients with COPD in-
volved the diagnosis of COPD according to the Global
Initiative for Chronic Obstructive Lung Disease [25], ages
between 50 and 65 years, absence of self-report of swal-
lowing/feeding difficulties and absence of prior swallowing
management. The exclusion criteria for subjects with
COPD were as follows: comorbidities and/or past history
of disease affecting the clinical course of COPD and swal-
lowing mechanisms (e.g. additional respiratory diseases,
malignant diseases, otorhinolaryngeal diseases, stroke, or
active inflammatory disorders other than COPD); with-
drawal of COPD-related medication; use of oxygen and/or
ventilation during the research period.
The healthy control subjects were matched for age and
gender to the COPD patients and were recruited from in-
dividuals who visited the Hospital for health status check-
ups. All controls were non-smokers and did not present
previous smoking habits. The exclusion criteria for the
control subjects were as follows: presence of comorbidities
of respiratory disorders including COPD; presence of co-
morbidities and/or a past history of disease affecting the
clinical course of swallowing mechanisms (e.g. malignant
diseases, otorhinolaryngeal diseases, stroke, or active in-
flammatory disease); self-report of swallowing/feeding dif-
ficulties and prior swallowing management.
Thus, our final study population included 20 patients
with COPD, 10 males and 10 females, with a mean age
of 59 years (±4.1), and 20 healthy controls, 10 males
and 10 females, also with a mean age of 59 years (±4.4)
(Figure 1). COPD patients presented the following smok-
ing habits: males 57.8(±40.0) packs per year; females 50.8
(±24.9) packs per year.
Measures
The variables considered to be baseline characteristics
were spirometry (i.e. forced expiratory volume during the
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first second - FEV1) and the body mass index (BMI) ob-
tained according to the National Institutes of Health and
the National Heart, Lung and Blood Institute (kg/m2).
Swallowing was assessed through videofluoroscopic
examination (VFSS). The fluoroscopy unit used for this
study was the GE Medical Systems, ADVANTX. All VFSS
were performed in a lateral plane by a videofluoroscopy-
trained radiographer and two speech and language thera-
pists at the same Hospital. Participants remained seated,
at an angle of 90°, with their heads positioned horizontally
according to the Frankfort plane (i.e. head parallel to
ground, considering the position of the inferior margin of
the left orbit and the upper margin of each external audi-
tory meatus), during the entire exam. Liquid barium
(Opti-bar) with 100% w/v was used. The protocol adopted
for the swallowing assessment involved the ingestion of
different food consistencies and was determined by the
Radiology Service. This assessment protocol is used
routinely at our Hospital for investigating swallowing
characteristics, especially the presence of aspiration,
and includes de following:
a) swallow of 3, 5 and 10 ml of liquid consistency (50%
water and 50% barium). The mixture was graded on a
disposable syringe and offered to the subjects in a cup;
b) swallow of 7 ml of paste consistency (20 ml of an
homogenous paste - apple puree by Néstle - and 5 ml
of barium). The mixture volume was measured using a
graded disposable syringe and was offered to the
subjects on a spoon;
c) swallow of solid consistency (half “salt and water”
biscuit dipped in 2.5 ml of the prepared paste
consistency).
For each one of the consistencies, the participants
were asked to swallow in their habitual manner in order
to avoid possible interferences in their swallowing
process. VFSS images were recorded on a VHS recorder
and later digitalized in DVDs at 30 frames per second.
In order to digitalize the obtained images, the software
TOO DVD Ripper Platinum v4.0.64 was used. Digita-
lized images were then viewed using the software
VitualDub v1.8.6, allowing a slow motion frame by
frame analysis and enabling the definition of the follow-
ing: (1) pharyngeal stages of deglutition; (2) the duration
of bolus movement through and pharynx (i.e. transit
times); (3) valleculae residue ratio [26]; (4) penetration/
aspiration.
VFSS analysis
Swallowing was analyzed by reviewing the digitalized
images of each swallow in slow motion. Temporal
measures of the critical physiologic events in the oro-
pharyngeal swallow and measurement of valeculae
residue for each swallow was performed and involved
the following:
1. Pharyngeal transit time – PTT [27]: the time
interval (in seconds) from the bolus head passing
through the ramus of the mandible (event 1) until
the bolus tail passes through the cricopharyngeal
sphincter (event 2). In order to determine this
measure, each one of the two events was
identified on the digital images. The conversion to
seconds was performed, considering that for the
used software each frame corresponds to
0.033 seconds;
2. Duration of the tongue base contact with the
posterior pharyngeal wall – TBC [27]: the time
interval (in seconds) from the first (event 1) until
the last (event 2) contact of the tongue base to the
posterior pharyngeal wall during swallowing. In
order to determine this measure, each one of the
two events was identified on the digital images. The
conversion to seconds was performed, considering
that for the used software each frame corresponds
to 0.033 seconds;
3. Valleculae Residue Ratio – VRR [26]: perceptual
two-dimensional ratio based on the analysis of the
Figure 1 Study population with COPD.
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height × width of the valleculae after the first
swallow. In order to determine the VRR the
following measurements were performed: (a) area
of the valleculae – this measure is obtained by
using an area function (height × width). The image
of the valleculae prior to swallowing is obtained by
freezing the digitalized image on the computer
screen. Measurements (height and width), in
millimeters, were performed on the actual
computer screen using a digital caliper. The
vallecuale height was considered the distance from
the tip of the epiglottis perpendicular to the base
of the valleculae and the width was considered
the widest horizontal portion of the valleculae
(Figure 2); (b) area of the residue – this measure
is obtained by using an area function (height ×
width) of the residue inside the valleculae. In order
to perform this measurement, the image of the
valleculae after the first swallowing of each one of
the tested volumes and consistencies is frozen on
the computer screen. The marker indicating the
end of a swallow was the termination of hyoid
motion post first swallow [28,29]. Measurements
(height and width), in millimeters, were performed
on the actual computer screen using a digital
caliper. The residue height was considered the
distance from the base of the valleculae residue
perpendicular to the residue top and the residue
width was considered the widest horizontal
portion of the valleculae residue (Figure 3);
(c) The VRR was determined by expressing the
area of the residue in the valleculae relative to the
area of the available space in the valleculae as
shown below:
area of residue=area of valleculaeð Þ  100%
¼ percentage of the valleculae occupied by residue
In order to guarantee reliability of the performed mea-
surements, all images were analyzed on the same com-
puter (notebook Dell Inspiron 1440) with the zoom tool
at 100%. After determining the percentage of the val-
leculae occupied by the residue, the severity was deter-
mined as shown on Table 1:
4. Penetration/Aspiration [30]: penetration/aspiration
was determined by using an 8-point multidimen-
sional perceptual scale. Depth of bolus invasion into
the airway is a major dimension. Scores were
attributed as follows: material does not enter the
airway (1); material enters the larynx but stays above
the vocal folds and is expelled from the airway
(2); material enters the airway, stays above the
vocal folds and is not expelled from the airway
(3); material enters the airway, touches the vocal
folds and is expelled from the airway (4); material
Figure 2 Area of the valleculae.
Figure 3 Area of residue.
Table 1 Severity scale for valleculae residue
Severity Percentage of residue in vallecular space
Normal <3
Mild ≥3 a <25
Moderate ≥25 a <55
Severe ≥55
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enters the airway, touches the vocal folds and is not
expelled from the airway (5); material enters the
airway, passes below the vocal folds and is expelled
from the airway (6); material enters the airway,
passes below the vocal folds and is not expelled from
the airway; material enters the airway, passes below
the vocal folds and no effort is made to expel it.
Scores 2 through 8 is assumed to be a more severe
sign of dysphagia. Aspiration is scored 6, 7, or 8.
Penetration is scored 2, 3, 4, or 5.
Measurement of reliability
Inter- and intrarater reliability was measured using
weighted kappa, which corrects for the effect of chance
and bias. By definition, weighted kappa ranges from 0
(chance agreement) to 1 (complete agreement).
Patient and control subject videofluoroscopic studies
were randomly analyzed (20% of the total VFSS samples)
by three independent speech and language pathologist
who were blinded to subject status (COPD vs control
subjects) and were not involved in performing the swal-
lowing study. Kappa was calculated for the residue ratio
after the numeric measurements had been categorized
as percentages. The interjudge and intrajudge reliability
ranged from 0.75 to 0.86 and 0.79 to 0.87 respectively.
Data analysis
All quantitative data were entered in a SPSS 17.0 database.
The Kolmogorov-Smirnov test was used to verify data dis-
tribution. The Mann–Whitney test was used for within
and between-group comparisons and the Spearman rank
correlation coefficients examined any linear association
among selected variables. Pearson's chi-squared test was
used to compare categorical variables and the Friedman
two-way analysis of variance by ranks was used to detect
differences across multiple test attempts. The adopted sig-
nificance level was of 5% for all analysis.
Results
Table 2 shows the characterization of age, body mass index
and spirometry (FEV1) of COPD patients and healthy indi-
viduals. The age and BMI were similar between patients
with COPD and healthy controls, whereas FEV1 differed
significantly between the two groups. Regarding the spiro-
metric classification of severity, patients presented the
following distribution: 2 at stage I (mild); 2 at stage II
(moderate); 11 at stage III (severe); and 5 at stage IV (very
severe).
Participants, i.e. stable COPD patients and healthy
controls, did not present any signs of penetration-
aspiration for any of the tested consistencies, receiving a
score of 1 on the penetration-aspiration scale. Tables 3
and 4 shows between-group comparisons for the PTT,
TBC and distribution of individuals among the different
severity levels of valleculae residue. Patients with COPD
presented longer PTTs during the ingestion of 10 ml of
the liquid consistency and during the ingestion of the
paste consistency. Regarding the TBC, COPD patients
also presented longer durations for the liquid (i.e. 5 ml)
and paste consistencies. No significant difference was
observed for the distribution of individuals among the
different valleculae residue severity levels.
Table 2 Characterization of participants
Variables COPD mean(SD) Control mean(SD) p-value
Age, years 59(4.1) 59(4.4) 0.880
BMI, Kg/m2 26.8(7.1) 28.5(5.9) 0.090
FEV1 43.3(20.9) 101(11.9) 0.000*
Legend: COPD – chronic obstructive pulmonary disorder; SD – standard
deviation; BMI – body mass index; FEV1 - forced expiratory volume during the
first second; * - significant results.
Table 3 Between-group comparison for transit times (in seconds)
PTT mean(SD) U p-value TBC mean(SD) U p-value
3 ml Liquid
COPD 1.22(1.26)
135.5 .080
.62(.27)
148.5 .162
Control .81(.29) .55(.30)
5 ml Liquid
COPD 1.32(.87)
136.0 .083
.95(.79)
94.0 .004*
Control 1.04(.60) .51(.24)
10 ml Liquid
COPD 1.25(.67)
82.5 .001*
.93(.58)
134.0 .070
Control .96(.63) .66(.39)
Paste
COPD 1.44(1.98)
107.5 .012*
.92(.45)
119.0 .028*
Control .80(.25) .62(.24)
Solid
COPD 1.56(2.07)
141.0 .110
.56(.11)
153.0 .201
Control 1.02(1.04) .52(.12)
Legend: COPD – chronic obstructive pulmonary disorder; SD – standard deviation; PTT – pharyngeal transit time; TBC – duration of tongue base contact with the
posterior pharyngeal wall; * - significant results.
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Spearman correlation coefficients were used to exam-
ine whether baseline characteristics correlated with tran-
sit time variables. Significant correlations were observed
not only for COPD patients, but also for healthy individ-
uals. Regarding the different food consistencies, the fol-
lowing significant correlations were observed:
 3 ml of liquid consistency – for healthy individuals
the longer the PTT the longer the TBC (Table 5);
 5 ml of liquid consistency – for healthy individuals
the higher the BMI the longer the TBC, and the
longer the PTT the longer the TBC; for COPD
patients the more severe the disease the shorter the
PTT (Table 6);
 paste consistency – for healthy individuals the
higher the BMI the longer the TBC (Table 7).
Within group comparisons were also performed in order
to verify possible differences in pharyngeal transit times
and in durations of tongue base contact with the posterior
pharyngeal wall among the tested volumes (Table 8). A
significant difference was observed only for the group of
COPD patients when considering TBC. Multiple com-
parisons of TBC for COPD patients however, indicated
no significant differences among the tested volumes. A
trend to significance was observed for the following
comparsions: 3 ml versus 10 ml (p = .060) and 10 ml
versus solid (p = .069). In both situations, longer dura-
tions of TBC were observed during the swallow of 10 ml
water (0.62 s for 3 ml water; 0.93 s for 10 ml water; and
0.56 s for solid).
Discussion
To the best of our knowledge, this is the first clinical
study providing detailed analysis of valleculae residue in
stable patients with COPD and with no swallowing com-
plaints. The data suggests that the risk for aspiration in
COPD population is not limited to the presence of val-
leculae residue.
Valleculae residue is an important indicator of swallow
efficiency and is a significant part of swallow studies
[31]. Where large quantities of valleculae residue exist,
the individual is at increased risk of aspirating residue
during respiration after swallowing [26]. Videofluoro-
scopic swallow studies have demonstrated that when there
is insufficient contact between base tongue and posterior
pharyngeal wall, residue remains in the valleculae [26]. In
our study, COPD patients presented longer durations of
tongue base contact with the posterior pharyngeal wall.
Studies by Mokhlesi et al. [11] reported reduced laryngeal
elevation during swallow in COPD and an overall altered
swallow physiology in the disease. As COPD patients tend
to present delayed swallowing reflex and problems with
lingual and pharyngeal peristalsis [16,20], we suspect that
Table 4 Between-group comparison for valleculae residue
None
(n)
Mild
(n)
Moderate
(n)
Severe
(n)
p-value
3 ml liquid
COPD 12 7 1 -
.322
Control 15 3 2 -
5 ml liquid
COPD 12 4 3 1
.695
Control 11 6 3 -
10 ml liquid
COPD 12 7 - 1
.249
Control 11 6 3 -
Paste
COPD 13 6 1 -
.809
Control 13 5 2 -
Solid
COPD 16 3 1 -
.766
Control 16 2 2 -
Legend: COPD – chronic obstructive pulmonary disorder; n – number
of individuals.
Table 5 Spearman correlation coefficient for 3 ml liquid
COPD Control
VEF1 BMI PTT VEF1 BMI PTT
PTT
r .201 .760 .045 .022
p-value .395 .751 .850 .928
TBC
r .359 .185 .311 .080 .365 .582
p-value .120 .429 .183 .736 .113 .007*
Legend: COPD – chronic obstructive pulmonary disorder; FEV1 - forced
expiratory volume during the first second; BMI – body mass index;
PTT – pharyngeal transit time; TBC - duration of tongue base contact with the
posterior pharyngeal wall; * - significant results.
Table 6 Spearman correlation coefficient for 5 ml liquid
COPD Control
VEF1 BMI PTT VEF1 BMI PTT
PTT
r .569 .335 .096 .025
p-value .009* .149 .686 .916
TBC
r .088 .150 .118 .360 .551 .473
p-value .712 .529 .620 .120 .012* .035*
Legend: COPD – chronic obstructive pulmonary disorder; FEV1 - forced
expiratory volume during the first second; BMI – body mass index;
PTT – pharyngeal transit time; TBC - duration of tongue base contact with the
posterior pharyngeal wall; * - significant results.
Table 7 Spearman correlation coefficient for pasty
consistency
COPD Control
VEF1 BMI PTT VEF1 BMI PTT
PTT
r .330 .109 -.074 .131
p-value .155 .649 .757 .583
TBC
r .154 .121 .386 -.095 .503 .216
p-value .517 .612 .093 .691 .024* .360
Legend: COPD – chronic obstructive pulmonary disorder; FEV1 - forced
expiratory volume during the first second; BMI – body mass index;
PTT – pharyngeal transit time; TBC - duration of tongue base contact with the
posterior pharyngeal wall; * - significant results.
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this mechanism may work as a protective physiologic
swallowing maneuver, explaining the absence of swallow-
ing complaints and aspiration in our study.
The same hypothesis could account for the longer dur-
ation of the pharyngeal transit times in COPD patients.
Because the pharynx is a shared pathway for food and
air intake, pulmonary protection necessitates a high level
of coordination between respiration and swallowing [13].
Palouski et al. [32] have suggested that longer duration
of the pressure waves are related to longer bolus transit
times and higher pharyngeal residue. According to the
authors, these correlations indicate that longer durations
of the pressure waves are associated with worse swallow
function, suggesting that a longer duration of pressure is
need to initiate and maintain bolus transit in the context
of reduced pharyngeal pressure. In our study, the longer
pharyngeal transit times could mean, at least in stable
patients with COPD, that breathing/swallowing events
would have more time to reach coordination before the
swallowing reflex itself is triggered. The same would not
be true for patients with COPD exacerbations. Since
exacerbations of COPD are characterized by acute-on-
chronic deterioration in respiration [1], patients are
most likely to have difficulties in prolonging swallowing
events especially those events that have a close relation-
ship to bringing respiration to a halt.
Another point that we would like to comment on, is
that pharyngeal transit times were longer for the larger
liquid volumes and for the paste consistency. Consistent
with previous reports, textural properties (i.e. viscosity)
and volumes of test foods can have an impact on the sen-
sory motor aspects of swallowing and therefore affect
some of the assessed durational parameters [33,34]. The
literature suggests that by increasing the bolus volume the
duration of swallowing events is prolonged (i.e. pharyngeal
and laryngeal). It seems that this phenomenon becomes
more evident if individuals already present alterations in
swallowing [35].
Although not evaluated in the present study, decreased
laryngopharyngeal sensitivity must also be taken into
account. Recently, studies of Clayton et al. [21] have re-
ported that the impairment of swallowing shown by pa-
tients with COPD is possibly caused by a reduction in
laryngopharyngeal sensitivity. The authors conclude that
patients with COPD have significantly less mechanosen-
sitivity in the laryngopharynx that may be related to the
effects of widely used medication on the laryngopharyn-
geal sensation and also to laryngeal edema caused by
chronic coughing. One might argue that these factors
may have an influence on the overall sensitivity of the
oral tract and therefore could affect the overall swallowing
process. Although we strongly believe that physiological
adaptations would respond for the longer durations of
measured transit times, the hypothesis of decreased oral
tract sensitivity should be further investigated.
Our study found no significant difference between stable
COPD patients and their healthy controls for valleculae
residue. We believe that age influenced our results, in the
sense that no difference was observed between the groups
as we had expected. Prior studies [36] have described the
presence of valleculae residue (pharyngeal retention) in
healthy older adults and elderly who are not aware of
this pharyngeal pooling [37]. A study by Cook et al. [36]
showed that although pharyngeal clearance is nearly
complete in young asymptomatic subjects, this is not
true in asymptomatic (non-dysphagic) elderly. In the
aged, pharyngeal residuals ranged widely from 1 to 13%.
Tracy et al. [38] found post-swallow residue to be lim-
ited to coating of the tongue base and the valleculae.
The mechanism responsible for the development of
pharyngeal retention in asymptomatic older individuals
are not well known. According to the literature [39-41],
different parameters may be involved such as amplitude
of pharyngeal contraction, pharyngeal shortening, tongue
driving force and hypopharyngeal suction pump. Future
studies should include the investigation of swallowing in
different age groups of COPD patients.
Our study had some limitations. First, patients with
COPD were heterogeneous. Although all patients included
in the study were in a stable condition, they presented dif-
ferent spirometric classification of severity. One would
expect valleculae residue to have a greater impact and
consequence in more severe forms of COPD due to the
interaction between lung deterioration and swallowing bio-
dynamic. This point should be included in future research.
Secondly, the method used to quantify pharyngeal residue
is applied only to the valleculae, with no corresponding
measurement for the piriform sinuses. It has been well
Table 8 Within group volume comparisons for PTT and TBC
Group Variable 3 ml 5 ml 10 ml Paste Solid p-value
COPD
PTT 1.22(1.26) 1.32(0.87) 1.25(0.67) 1.44(1.98) 1.56(2.07) .720
TBC 0.62(0.27) 0.95(0.79) 0.93(0.58) 0.92(0.45) 0.56(0.11) .004*
Control
PTT 0.81(0.29) 1.04(0.60) 0.96(0.63) 0.80(0.25) 1.02(1.04) .291
TBC 0.55(0.30) 0.51(0.24) 0.66(0.39) 0.62(0.24) 0.52(0.12) .243
Values expressed by mean and standard deviation; Friedman two-way analysis of variance by ranks.
Legend: COPD – chronic obstructive pulmonary disorder; PTT – pharyngeal transit time; TBC - duration of tongue base contact with the posterior pharyngeal wall;
* - significant results.
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described that material retained in the piriform sinuses also
constitutes a risk for post-swallow aspiration [42]. More-
over, the VRRS is related to the method used for calculat-
ing area (linear height by linear width). Recently, Pearson
et al. [43] proposed an image-based measurement of
post-swallow residue (the Normalized Residue Ratio Scale)
based on the analyses of circumscribed area ratios (pixel-
based). Although this method still needs further investiga-
tion, it is a promising tool to characterize residue in the
valleculae and piriform sinuses.
Even though dysphagia is part of the symptoms pre-
sented by COPD patients, little emphasis is given to the
early identification of swallowing alterations; attention is
only given when the patient is already severely compro-
mised. Treatment of COPD involves lifestyle modifica-
tions. Early identification of swallowing disorders enables
early oral rehabilitation (i.e. compensatory strategies, diet
modification), which in turn could decrease the risk of as-
piration pneumonia. Finally, future studies are necessary
in order to investigation the deterioration process of swal-
lowing in this population and how and which rehabilita-
tion processes can maintain this function healthy for a
longer period of time.
Conclusions
This study adds to the growing body of literature sug-
gesting that stable COPD patients may present physio-
logical adaptations as a protective swallowing maneuver
to avoid aspiration/penetration of pharyngeal contents.
Moreover, valleculae residue cannot be seen as an isolated
factor when trying to explain swallowing alterations in this
population.
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